Global Irritable Bowel Syndrome (IBS) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Name: Global Irritable Bowel Syndrome (IBS) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Brand: GlobalInfoResearch
SKU: GC9C7159021GEN
Price: 3480 USD
Availability: InStock

August 2018 | 119 pages | ID: GC9C7159021GEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.

SCOPE OF THE REPORT:

This report focuses on the Irritable Bowel Syndrome (IBS) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Irritable Bowel Syndrome (IBS) Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Valeant Pharmaceuticals International
Ardelyx
Astellas Pharma
Novartis
GlaxoSmithKline
Ironwood Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor

Market Segment by Applications, can be divided into

Hospital
Research

There are 15 Chapters to deeply display the global Irritable Bowel Syndrome (IBS) Therapeutics market.

Chapter 1, to describe Irritable Bowel Syndrome (IBS) Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Irritable Bowel Syndrome (IBS) Therapeutics, with sales, revenue, and price of Irritable Bowel Syndrome (IBS) Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Irritable Bowel Syndrome (IBS) Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Irritable Bowel Syndrome (IBS) Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

1 MARKET OVERVIEW

1.1 Irritable Bowel Syndrome (IBS) Therapeutics Introduction
1.2 Market Analysis by Type
  1.2.1 Blautix (Strain)
  1.2.2 Bekinda (IBS-D)
  1.2.3 SYN-010
  1.2.4 Tenapanor
1.3 Market Analysis by Applications
  1.3.1 Hospital
  1.3.2 Research
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Abbott Laboratories
  2.1.1 Business Overview
  2.1.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Synergy Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sucampo Pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Valeant Pharmaceuticals International
  2.4.1 Business Overview
  2.4.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ardelyx
  2.5.1 Business Overview
  2.5.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Pharma
  2.6.1 Business Overview
  2.6.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
  2.7.1 Business Overview
  2.7.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline
  2.8.1 Business Overview
  2.8.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ironwood Pharmaceuticals
  2.9.1 Business Overview
  2.9.2 Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturer Market Share in 2017
  3.3.2 Top 6 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS MARKET ANALYSIS BY REGIONS

4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Regions
  4.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)

5 NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS BY COUNTRIES

5.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Countries
  5.1.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)

6 EUROPE IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS BY COUNTRIES

6.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Countries
  6.1.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS BY COUNTRIES

7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS BY COUNTRIES

8.1 South America Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Countries
  8.1.1 South America Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)

10 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales and Market Share by Type (2013-2018)
  10.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Blautix (Strain) Sales Growth and Price
  10.2.1 Global Blautix (Strain) Sales Growth (2013-2018)
  10.2.2 Global Blautix (Strain) Price (2013-2018)
10.3 Bekinda (IBS-D) Sales Growth and Price
  10.3.1 Global Bekinda (IBS-D) Sales Growth (2013-2018)
  10.3.2 Global Bekinda (IBS-D) Price (2013-2018)
10.4 SYN-010 Sales Growth and Price
  10.4.1 Global SYN-010 Sales Growth (2013-2018)
  10.4.2 Global SYN-010 Price (2013-2018)
10.5 Tenapanor Sales Growth and Price
  10.5.1 Global Tenapanor Sales Growth (2013-2018)
  10.5.2 Global Tenapanor Price (2013-2018)

11 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Research Sales Growth (2013-2018)

12 IRRITABLE BOWEL SYNDROME (IBS) THERAPEUTICS MARKET FORECAST (2018-2023)

12.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast by Regions (2018-2023)
  12.2.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
  12.2.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
  12.2.4 South America Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
12.3 Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast by Type (2018-2023)
  12.3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Type (2018-2023)
  12.3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast by Application (2018-2023)
  12.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Application (2018-2023)
  12.4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

LIST OF TABLES AND FIGURES

Figure Irritable Bowel Syndrome (IBS) Therapeutics Picture
Table Product Specifications of Irritable Bowel Syndrome (IBS) Therapeutics
Figure Global Sales Market Share of Irritable Bowel Syndrome (IBS) Therapeutics by Types in 2017
Table Irritable Bowel Syndrome (IBS) Therapeutics Types for Major Manufacturers
Figure Blautix (Strain) Picture
Figure Bekinda (IBS-D) Picture
Figure SYN-010 Picture
Figure Tenapanor Picture
Figure Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Research Picture
Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Irritable Bowel Syndrome (IBS) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ardelyx Basic Information, Manufacturing Base and Competitors
Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Type and Applications
Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Regions (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions in 2013
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions in 2017
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries in 2013
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries in 2017
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2013
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2017
Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure France Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries 2017
Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure India Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries in 2017
Table South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales and Growth Rate (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Type (2013-2018)
Figure Global Blautix (Strain) Sales Growth (2013-2018)
Figure Global Blautix (Strain) Price (2013-2018)
Figure Global Bekinda (IBS-D) Sales Growth (2013-2018)
Figure Global Bekinda (IBS-D) Price (2013-2018)
Figure Global SYN-010 Sales Growth (2013-2018)
Figure Global SYN-010 Price (2013-2018)
Figure Global Tenapanor Sales Growth (2013-2018)
Figure Global Tenapanor Price (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Application (2013-2018)
Figure Global Research Sales Growth (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
Figure South America Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Application (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Global Irritable Bowel Syndrome (IBS) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

More Publications

Need Help?

Ask a Question

Market Reports